New podcast episode with @szusmani & @SagarLonialMD on the journey of belantamab mafodotin in #MM. Listen now 🎧.

ICYMI: NCCN recommends pemivibart for #BCL patients at risk of severe COVID-19 .

In this video interview, Dr. Anastasia Vasileva, a researcher at the National Research Center for Hematology in Moscow, discusses findings from a study on adult patients with Ph-negative #ALL #EHA2025 .

FDA grants accelerated approval to linvoseltamab in R/R #myeloma #MedTwitter .

"We can say that vitamin D is more prognostic rather than predictive," Dr. Lazic said about this #18ICML study on vitamin D in #DLBCL.

Milan was sizzling, but our SOHO President @scheinbp says the real heat is coming to Houston🔥. Register at for #SOHO2025 #teaser .

Thank you @KuykendallMd for stopping by the #SOHO booth to discuss the phase 3 VERIFY trial in #PV.

One day. Zero travel. All the insights. Get the latest #bloodcancer updates from world-renowned experts without leaving your desk! Join us for Breakthroughs in Blood Cancers, chaired by @DrHKantarjian. 📅Nov 20.💻Zoom.🆓for SOHO Members. Register👉#hemonc

Read our current SOHO Insider issue online now with Elie Jabbour, @garciamanero @heMEGirl_MD Charles Craddock & more.

Study supports frontline use of imetelstat for low-risk MDS patients ineligible for ESAs #EHA2025 .

Dr. Rami Komrokji is personally inviting YOU to #SOHO2025. Don't let him down. Register today at 💯 @Ramikomrokji

FDA drops REMS requirement for 6 CAR-T therapies.

Some inspo via @NHMLA.

These apex predators ruled their field. Want to rule yours? Join SOHO today as a member and get the tools you need to lead. .#SOHO2025

Real-world study shows that luspatercept is superior to ESA in LR-MDS, Idoroenyi Amanam, MD, says. @aMyeloidPersona .

ELARA trial: tisagenlecleucel response extends to 4 years in follicular lymphoma #18ICML #lugano2025.

Drs. Jabbour and Daver talk about #AML challenges & SOHO updates in this new podcast episode 🎧.

Fresh out of Milan & still styling 😍.Donate to support young investigators and global blood cancer programs & get UR SOHO T-shirt @MDAndersonNews @DrHKantarjian @sanamloghavi .🩸 Donate now and wear it proud:

10K strong & growing!🎉SOHO celebrates a major milestone thanks to you, our incredible community advancing hematologic oncology worldwide. Let’s continue to innovate, collaborate & transform patient care together!. Not a member? Join SOHO for free: #hemonc

“We’re starting to see that patients treated with luspatercept have significantly longer survival compared to those treated with epoetin alfa,” @garciamanero said. @bmsnews .